dc.contributor.author | Teker, Erhan | |
dc.contributor.author | Bugra, Zehra | |
dc.contributor.author | Akadam-Teker, Basak | |
dc.contributor.author | Yilmaz-Aydogan, Hülya | |
dc.contributor.author | Ozkara, Gulcin | |
dc.contributor.author | Kurnaz-Gomleksiz, Ozlem | |
dc.contributor.author | Ozturk, Oguz | |
dc.date.accessioned | 2021-03-06T07:55:13Z | |
dc.date.available | 2021-03-06T07:55:13Z | |
dc.identifier.citation | Akadam-Teker B., Ozkara G., Kurnaz-Gomleksiz O., Bugra Z., Teker E., Ozturk O., Yilmaz-Aydogan H., "BMP1 5'UTR+104 T/C gene variation: can be a predictive marker for serum HDL and apoprotein A1 levels in male patients with coronary heart disease", MOLECULAR BIOLOGY REPORTS, cilt.45, ss.1269-1276, 2018 | |
dc.identifier.issn | 0301-4851 | |
dc.identifier.other | av_de825ce5-dd24-410c-a57d-78d8ce70c0f2 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/146605 | |
dc.identifier.uri | https://doi.org/10.1007/s11033-018-4283-8 | |
dc.description.abstract | Apolipoprotein A1 (Apo A1), the major protein of HDL, is secreted as a proprotein and then is cleaved by C-terminal procollagen endoproteinase/bone morphogenetic protein-1 (BMP1). BMP1 stimulates the conversion of newly secreted proapo A1 to its phospholipid-binding form. Therefore, genetic variations of BMP1 gene may affect serum ApoA1 and HDL levels. We aimed to investigate the effects of the functional 5'UTR + 104 (T/C) variant of BMP1 on serum ApoA1 and HDL levels and risk of coronary heart disease (CHD) in this study. The BMP1 5'UTR + 104 (T/C) (rs143383) variation was determined in 131 male patients with CHD and 51 male controls by real-time polymerase chain reaction technique. ApoA1 levels were measured by immunoturbidimetry. The serum Apo-A1 levels were found higher in controls with the BMP1-CC genotype than those with the T-allele (p < 0.001). Our findings show the association of this variation with serum ApoA1 and HDL-C levels which increase in the order of CT < TT < CC in the controls. No effect was found on ApoA1 and HDL-C levels in CHD patients, as it was observed in the controls. However, the BMP1-TT genotype was associated with higher triglyceride (TG) levels as compared to C-allele (p = 0.009). These discrepancies could be due to statin therapy which has dominant effects on lowering cholesterol levels comparing to TG levels. Our results indicated that the BMP1 5'UTR + 104 (T/C) variation may affect the serum ApoA1 and lipoprotein levels depending on statin therapy so that contributes to the development of CHD. | |
dc.language.iso | eng | |
dc.subject | Structural Biology | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Temel Bilimler | |
dc.subject | Biochemistry, Genetics and Molecular Biology (miscellaneous) | |
dc.subject | Clinical Biochemistry | |
dc.subject | Cancer Research | |
dc.subject | Molecular Biology | |
dc.subject | Drug Discovery | |
dc.subject | Aging | |
dc.subject | General Biochemistry, Genetics and Molecular Biology | |
dc.subject | Biochemistry | |
dc.subject | Life Sciences | |
dc.title | BMP1 5'UTR+104 T/C gene variation: can be a predictive marker for serum HDL and apoprotein A1 levels in male patients with coronary heart disease | |
dc.type | Makale | |
dc.relation.journal | MOLECULAR BIOLOGY REPORTS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 45 | |
dc.identifier.startpage | 1269 | |
dc.identifier.endpage | 1276 | |
dc.contributor.firstauthorID | 2370140 | |